fatnews.com Fatnews Bitchute Channel Link Home page  >  Article | Previous article | Next article

SEARCH

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Belviq (lorcaserin) increases risk of depression 1.9-fold


    Posted by .(JavaScript must be enabled to view this email address)
    Saturday, November 01, 2014 1:28 pm Email this article

    Belviq (lorcaserin), a weight loss drug, is associated with a 1.9-fold increase in the risk of depression according to a paper looking at side effects of the drug written by James DiNicolantonio, PharmD and others.

    This finding was based on a pooled analysis of three randomized controlled trials testing lorcaserin 10 mg twice daily versus placebo.

    Reference

    DiNicolantonio JJ, Chatterjee S, O’Keefe JH, and Meier P. Lorcaserin for the treatment of obesity? A closer look at its side effects. Open Heart, 2014; 1(1): http://openheart.bmj.com/content/1/1/e000173.full.

    Author’s Contact Info

    James J. DiNicolantonio, PharmD
    Associate Editor BMJ Open Heart
    Cardiovascular Research Scientist
    Saint Luke’s Mid America Heart Institute
    http://www.saintlukeshealthsystem.org/dinicolantonio
    https://www.researchgate.net/profile/James_Dinicolantonio
    https://twitter.com/jjdinicol
    .(JavaScript must be enabled to view this email address)


    Articles on the same subject can be found here:


    COMMENTS

    Please feel free to share your comments about this article.


    Name:

    Email:

    Comments:

    Please enter the word you see in the image below:


    Remember my personal information

    Notify me of follow-up comments?



    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.